Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Otsuka Holdings Co's quarterly common stock
stayed the same
from Dec. 2025 (円81,690 Mil) to Mar. 2026 (円81,690 Mil) and
stayed the same
from Mar. 2026 (円81,690 Mil) to Jun. 2026 (円81,690 Mil).
Otsuka Holdings Co's annual common stock
stayed the same
from Dec. 2023 (円81,690 Mil) to Dec. 2024 (円81,690 Mil) and
stayed the same
from Dec. 2024 (円81,690 Mil) to Dec. 2025 (円81,690 Mil).
The historical data trend for Otsuka Holdings Co's Common Stock can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otsuka Holdings Co (TSE:4578) has a Common Stock of 円81,690 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Otsuka Holdings Co and its competitors.
Is Otsuka Holdings Co's Common Stock too high?
Otsuka Holdings Co's current Common Stock is 円81,690 Mil. Overall, Otsuka Holdings Co has a GF Score™ of 88/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Common Stock compare to LLY and JNJ?
Otsuka Holdings Co's Common Stock of 円81,690 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Otsuka Holdings Co and its competitors. Otsuka Holdings Co's current Common Stock is 円81,690 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (TSE:4578) is currently considered Significantly Overvalued. The stock's GF Value™ is 円9,042.22, compared to a current price of 円11,805.00 — trading 30.6% above its estimated fair value. The current Common Stock is 円81,690 Mil. Otsuka Holdings Co's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Otsuka Holdings Co (TSE:4578), the current Common Stock is 円81,690 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Otsuka Holdings Co (TSE:4578) Overvalued in 2026?
Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued.
The current stock price of 円11,805.00 is trading 30.6% above its estimated GF Value™ of 円9,042.22.
GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4578:
Common Stock: 円81,690 Mil
GF Value™: 円9,042.22 vs. price of 円11,805.00 (30.6% above fair value)
No single metric tells the full story. See the TSE:4578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
88GF Score
Get the complete analysis for TSE:4578
Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4578 has been successfully added to your 
